跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VYDURA 75 MG LIOFILIZADO ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VYDURA 75 MG LIOFILIZADO ORAL
Approved
STANDARD
VYDURA 75 MG LIOFILIZADO ORAL
Pfizer Europe Ma Eeig
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 6, 2022
Approval ID
d02ab23989066bc5
Company
Pfizer Europe Ma Eeig
Type
Standard
Approval Details
Approval Id
d02ab23989066bc5
Drug Cima Aemps Name
VYDURA 75 MG LIOFILIZADO ORAL
Register Number
1221645002
Holder Company Name
Pfizer Europe Ma Eeig
Marketing Company Name
Pfizer S.L.
Holder Company Detail Path
/organization/pfizer-europe-ma-eeig
Authorization Date
2022-06-06
Dosage Form
LIOFILIZADO ORAL
Dose
75 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Pfizer Europe Ma Eeig
Company Detail Path
/organization/pfizer-europe-ma-eeig
Company Information
Pharmaceutical Company Name
Pfizer Europe MA EEIG
Country Name
United Kingdom
Active Ingredients
RIMEGEPANT SULFATO
85,65 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 6, 2022
Approval ID
d02ab23989066bc5
Type
Standard
Back to CIMA-AEMPS Approvals